Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VPS51 (Vacuolar protein sorting-associated protein 51 subunit of GARP complex) is one of four essential components of the Golgi-associated retrograde protein (GARP) complex, which also includes VPS52, VPS53, and VPS54[1][2][3]. The complex is located at the trans-Golgi network (TGN) and functions primarily to tether and facilitate the fusion of retrograde transport vesicles derived from endosomes to the TGN[1][3][4]. VPS51 is specifically required for the complex's association with SNARE proteins (notably the t-SNARE Tlg1p in yeast, orthologous to syntaxin 6 in mammals), regulating the retrieval of cargo and protein recycling from endosomes to the Golgi[2]. Deficiency or malfunction of VPS51 leads to defects in vesicle trafficking and lysosomal function, with disease links to pontocerebellar hypoplasia and lissencephaly[4]. VPS51’s molecular role is best classified as a vesicle tethering factor, with no direct evidence of receptor, enzyme, or transporter activity. It is not a current therapeutic drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vacuolar protein sorting-associated protein 51 subunit of GARP complex (VPS51).